These results suggest that the preoperative serum CD109 levels can detect poor prognostic HNSCC cases with node metastasis and that the CD109 index can predict patients who are at risk of locoregional recurrence or distant metastasis. Here, CD109 is linked to head and neck squamous cell carcinoma.